September 21 2022 Networking Event Summary

The GLSA | FOCM Networking Event on Wednesday, September 21, 2022 at 5:00 PM EST was a fascinating presentation by Patrick McCarthy and Steve Galen of Validcare about a disruptive approach to the conduct of clinical trials. Recent advances in technology and learning to do things remotely due to COVID-19 helps make this possible. Not only is it possible, it is being done and Validcare is at the forefront.

https://validcare.globallifesciencesalliance.com/

The current clinical trial paradigm is broken. Decentralized clinical trials are proving not to be the solution. They’re merely a bolt-on expense that helps with patient access and engagement. DCTs do not reduce costs nor delays caused by inefficient data management, staffing and software systems. Validcare’s Digital 1st CRO Experience succeeds where DCTs do not. Finally we have the ability to fix the CRO Model and put an end to low-ball proposals to win the project followed by significant change orders shortly after study start-up.

Validcare’s platform puts the entire study in one cloud environment. This has been built by experienced industry insiders who knew that to fix the CRO model it had to be re-engineered from the outside. The platform has been designed on these principles:

  • Transparency
  • High performance
  • Low maintenance
  • Turn-key

As such it provides for predictable financial performance allowing for a fixed price for study conduct.

To nobody’s surprise, we couldn’t stay away from discussing the Fall conference schedule and who was intended to go to which events. It looks like a full return to in-person events with DPharm, SCDM, OCT New England, CNS Summit, MAGI West, CTS East Coast, etc.

Andrew Mulchinski stated that Symbio hasn’t fully adapted to DCT yet, sparking the post-quarantine observations of many regarding the transition to decentralized and hybrid studies.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present on an educational life sciences topic and spur our event discussions, please leave a comment below and I’ll reach out as soon as possible.

Attendees (first time attendees in bold):

Julia Love, CEO, Love Contracts
Candy Dupree, National Sales Director, AdamsBridge Global
Himanshu Desai, Global Head PV QA, Novartis
Mike O’Gorman, CEO Life Science Marketplace
Mindy Bertram, Owner, CMB Consultants
Andrew Mulchinski, Business Development, Symbio Research
Wayne Whittingham, Vice President, Regulatory,  Cardio Pharma
Duncan Shaw, CEO, DTS Language Services
Katherine Cloninger, Senior Director, Brand Marketing, Parexel
Ravi Luthra, Clinical Research Coordinator

GLSA:
Chris Matheus
Joe Buser
Holly Cliffe
Denise McNerney
Sally Haller
Hannah Lloyd-Clark

A few screenshots are below:

Screenshot #1
Screen Shot #2
Screen Shot #3

Networking Pictures from SCDM 2017

I recall a much simpler time. I know this confession will highlight my years of experience (nicer way to say “old age”). In my working life time there was a 2 decade period where people could get in touch with you 1 of 3 ways: call you at your home phone number, contact you via a pager to call them or an answering service or mail you a letter/memo through internal company mail or US Postal service if you were remote.

So this realization hit me when I was going back through text messages to find pictures from past FOCM networking events for posting here. These are from 2017 at the Society for Clinical Data Management conference in Orlando. Nowadays (you don’t hear this word often enough – add another digression, as my friend Kevin Boos says, another phrase that we don’t use much any more is: “all the live long day”), you can be reached or reached out to via:

  1. email (and you probably have more than 1 email address – I have 5)
  2. Instagram message
  3. Facebook messenger
  4. Cellphone call
  5. Text to cellphone
  6. LinkedIn Message
  7. WhatsApp
  8. Instagram
  9. Twitter
  10. GoogleChat
  11. Venmo
  12. Paypal
  13. and the above are just the ones I know of – which means you can also be reached out/called out on MeWe, Telegram, Rumble, NextDoor and many others I am sure. Oh how could I forget the one I have to tend to the most: my OnlyFans account!! So many requests for pictures of my feet – barefoot, in sandals, huaraches, etc. But with each follower paying the monthly subscription fee, I’m netting around $10/month. I don’t have to tell you that over twelve months that’s around $120 straight to the bottom line.

Okay, back to the topic at hand, no more chasing shiny objects;

SCDM 2017 was held in Orlando. FOCM card carrying member Brian Langin with card # 00000001 encourages me to have a FOCM Networking event at Bob Marley – A tribute to Freedom in Universal CityWalk Orlando. And therefore, I do.

Entering into evidence the following two pictures:

Vicky Martin, Jennifer Price, Hugh Levaux, Karen McPoyle, Joby John, Tina Pietropaolo, Susan Howard and Karen Hicks.

The Brain Trust; Photo assumed to be taken by Brian Langin

Apologies for the darkness of the picture of Brian – at the time he was keeping a low profile due to some criminal or civil investigation of one type or another.

Anonymous Informant – Brian Langin

Meeting Summary July Virtual Networking

The GLSA | FOCM Networking Event on Wednesday, July 20th, 2022 at 5:00 PM EST was a lively affair boasting a diverse crowd of life science professionals. Many who attended were the previous colleagues and / or the current friends of Chris Matheus (FOCM, President; GLSA Chief Commercial and Networking Officer).

The topic of the day was “Summer Fun” due to the prevalence of the industry to go semi-dormant in July and August to accommodate the well-deserved vacations of its workers. The introduction, led by Chris, briefly spoke of former events which usually involved the related capabilities or education topic of a guest speaker to spur industry-related discussions and aid in collaboration among the group. He expressed the intention of this event to be focused more on the personal activities and vacations of attendees in order to keep our minds on the relaxation of these summer months. 

To nobody’s surprise, we couldn’t stay away from discussing work including the most recently held conferences; BIO International Convention in San Diego, CA and DIA Annual Meeting in Chicago, IL with a specific mention about the limited presence of sponsors. An outbreak of Coronavirus at these events and the apparently foul-tasting Paxlovid medicine used to treat moderate cases of COVID sparked conversation about who among us has contracted the virus and the varying degrees by which each individual was affected. 

Andrew Mulchinski stated that Symbio hasn’t fully adapted to DCT yet, sparking the post-quarantine observations of many regarding the transition to decentralized and hybrid studies. Chris noted a number of CRO’s that have changed leadership or have been acquired by other companies.

By far the most celebratory moment of the event was the announcement of the recent success of the Memorial Sloan Kettering Cancer Center in a small clinical trial using immunotherapy. They achieved 100% remission of rectal cancer without the use of surgery, chemotherapy or radiation that can leave patients with life-long effects including infertility and colostomy bags.

Let’s continue to reinforce our collective goal to improve patients’ lives across the globe. If you would like to present briefly on an educational life sciences topic and spur our event discussions, please contact me.

Attendees: (first time attendees in bold)

Kimberly Lupo, MS, MBA, RAC Founder & CEO at Portrett Pharmaceuticals LLC
Sara Tylosky CEO, Farmacon
Nadia M. Bracken Operational Advisor, Medidata
Brian Horan CEO & Co-founder, SupplyRx
Tina Tran Director, Business Development, Unlearn.ai
Heather Hollick Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Amy Zastawney Seeking a new executive business development role
Jon Matheus Commercial Real Estate, A.T. Pancrazi Real Estate Services
Unnat Patel Founder & President, AnalysisMate
Peter Payne Life Sciences Executive – Available for Consulting
Griffin Robertson Partner Account Manager, Mednet
Nancy Zeleniak Enterprise Strategic Partnerships & Participant Engagement; Atrium Health
Dhruv Wadhwa Director of Business Development, HUMA
Michael Young Founder & Principal, BIOMedworx
Scott Robertson Vice President of Sales, Global Partnerships; Mednet
Ravipal Luthra, MS, BDS Clinical Research Coordinator, University of Miami, Miller Medical Center
Andrew Mulchinski, MPA, MT, ASCP, CCRC Business Development; Symbio, LLC
Lani Hashimoto Associate Director Patient Engagement Management; Novartis
Amanda Putnam Team Lead Manager; Data Recognition Corporation
Michael O’ Gorman CEO and Founder at Life Science Marketplace
Eliana Burke Global Head of Client Engagement & Marketing; Greenlight Clinical
Michael Minor EVP, Clinical Research; IMA Clinical Research
Vaibhav Sawant Pharma Marketing Executive
GLSA ATTENDEES
Denise McNerney Chief Operations Officer
Hannah Lloyd Account Manager
Zulma Varela Director of Public Communications
Sally Haller Operations Manager
Todd Neilson Account Manager
Joe Buser Chief Revenue Officer
Chris Matheus Chief Commercial and Networking Officer
Yutong Liang Intern, Data Management and Technology

Screen shots of the event follow:

Screen shot at 5:06 Start of the event Screen shot at 5:18 Screen shot at 5:21

Break out rooms
Screen shot at 5:45
6:02 p.m. screenshot

Meeting Summary of May Networking Event

On May 18, the GLSA and FOCM held their monthly online networking event. We always start the meeting with some time for people to give an update on any news they’re heard or a significant event that has happened in the past month. Then we move to a featured presenter for 10 – 15 minutes presenting information about themselves, their company or a clinical research topic of relevance to them or to the industry.

This event featured Alison Macpherson, CEO and Founder of Bright Pharmaceutical Services, a full service CRO headquartered in Los Angeles.  Bright is celebrating their 20th year in business.
http://www.brightps.com/

Alison talked about her experiences starting out in the clinical trials industry and how that led to her forming Bright with a boutique sponsor-centric approach and a focus on subject recruitment and retention. The company has worked in a variety of therapeutic areas and all phases of research.  Its differentiators from other similar sized CRO’s is the very low turnover (less than 5%) over the 20 years in business, which means clients’ projects are supported by only very experienced and engaged staff. Additionally, while much of their experience is in phase I and II North America trials, they have worked in 30+ countries globally.  Questions were handled as they came up leading to discussions about Bright’s experience with risk-based monitoring; the new normal of hybrid and decentralized trials; reducing the frequency of subject visits to the sites; and Bright’s experience with trials that require collecting data from wireless, connected devices, e-source data, etc.

After the presentation we had first time participants share their company names and experience. Josh Lang, Mike O’Gorman and Denise McNerney will be attending BIO in San Diego June 13 – 16.  Carlos mentioned the networking event they are having on June 12 in San Diego for people interested in Farmacon Global’s August 25 conference focused on conducting clinical trials in Rare Diseases in Emerging Markets.In posing this question to the group – what are you working on and what do you need help with, Heather Hollick (who taught me this approach for successful networking) mentioned she is starting the Institute for Vibrant Leadership and could use connections to leaders, coaches with whom to collaborate as well as writers and virtual assistants. Subsequently, a few potential connection candidates have been sent to her. https://heatherhollick.com/

Attendees (bolded names indicate first time attendees):

Alison Macpherson, Bright Pharma Services
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Nicole O’Brien, Pain Care Labs
Josh Lang, Asymchem Group
Barbara Hilewsky, BRCR Global
Shane Krauss, Strados Labs
Carlos Martinez, Farmacon Global
David Holland, Cmed Research
Michael O’Gorman, Life Science Marketplace
Keisha Felix, IQVIA
Ludmilla Scodeler
Jim Choi, CRScube
Cesar Serapiao
Chris Matheus, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance

Several screen shots follow:

Bright Pharma Services

 

Screenshot of May 18 2022 event
Screen shot of May 18 2022 event

 

 

Networking from 2017

I am most definitely playing catch up with posts – but I’ve always been a strong believer or follower of the “better late than never” philosophy.

Here’s a picture of Bryan Clayton and Tope Keyes at a January 2017 Healthtech event.  I’ve seen them both recently as we’re returning to in -person conferences and networking events.

Bryan Clayton and Tope Keyes

 

 

 

 

 

and this next photo may have been taken at the same event – at least I do know it was also taken in January of 2017.  Brian Langin, Nithiya Ananthakrishnan, Deb Jendrasek and Rob Nichols. Please note neither Brian nor Rob have registration badges – it’s possible their attendance involved using the time honored Business Development technique known as “the Strand” or “the Langin”.

Brian Langin, Nithiya Ananthakrishnan, Deb Jendrasek, Rob Nichols

March Networking Event Summary

On March 16, the GLSA and FOCM held their monthly online networking event.  We start the meeting with a featured presenter spending 10 – 15 minutes presenting information about themselves and a clinical research topic of relevance to them.

This event featured Wessam Sonbol, founder of Delve Health. Wessam has been in the clinical research industry for 23 years. Many of these years have been in leadership and founding roles in the technology and product development to facilitate trials. He founded Delve Health in 2018.  Delve Health provides innovative decentralized clinical trial solutions to improve clinical trial conduct for patients, caregivers, doctors and pharma/device. Offerings include ePRO/eCOA, eConsent, study tasks, wearables and biosensor integration, EMR data collection and Real-world evidence capabilities.

After the presentation, there were questions, answers and discussions.  We then allowed newer participants the opportunity to tell us about their history in the industry and the group can be of help.

Attendees (bolded names indicate first time attendees):
Wessam Sonbol, Delve Health
Andrew Mulchinski, Symbio Research
Ravipal Luthra, University of Miami, Miller School of Medicine
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Michael Young, biomedwoRx: Life Sciences Consulting
Mike O’Gorman, Life Science Marketplace
Edwin Gershom, Noble Life Sciences
Taylor Biche, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

https://globallifesciencesalliance.com/

Please join us on April 20 where the featured presenter will be Amy Baxter, MD; CEO and Founder of Pain Care Labs. PCL’s NIH-funded pain relief device is an ingenious intervention to reduce needle pain and fear – improving patient participation in clinical trials.

Selected screen shots appear below:

Delve Health Presenting
Screenshot #1
Screen shot #3
Screenshot with Teddy in lower left
Screenshot #2

 

 

FOCM Members in Chicago at ASCO

Yes ’tis true I am only 8 years behind in posting photos of members captured at various conferences.

This photo was taken at ASCO in June of 2014 in Chicago.  American Society of Clinical Oncology (ASCO) has been held in June in Chicago for many, many years. It is one of the largest Oncology focused conferences.  It draws medical and clinical oncologist, oncology RNs, oncology NPs and PAs. The exhibit hall is huge and takes place at McCormick Center in Chicago.

I was working at YPrime at the time and was fortunate to be selected to attend. One of the things I love about conferences is running into friends and former co-workers. In most cases, its both. This time I ran into two of my favorites: Erica Hill and Sue Ruane. I’d  met them both while working at ICON Clinical Research.

 

Erica Hill, me, Sue Ruane

February Networking Event Summary

 

On February 16, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the second event of 2022 and like the January event, we again had 3 first-time attendees. Thank you to super-connector and FOCM member, Nadia Bracken for sharing our event with others.

We spent the first 15 minutes with introductions and general discussion about the weather in various attendees’ cities.  

This event featured a presentation by Kalyan Ghosh, Founder and CEO of Inference, Inc (https://inferenceinc.com/).  Inference, a GLSA client, was formed in 2017 by Kalyan.  He has over 25 years experience in clinical biostatistics, having worked at both big pharma (Merck and BMS) and CROs (Vislation, INC Research and West Coast Clinical Trials). Kalyan is an accomplished presenter and presented an overview of biostatistics and the role that data management and biostatistics have in drug development. 

Please join us next month on March 16 at 7:00 p.m.  Wessam Sonbol, CEO of Delve Health, an e-clinical technology platform service provider and client of GLSA will spend 10 – 15 minutes talking about their approach to patient-centered hybrid and decentralized studies in drug development.

ATTENDEES (bolded names were first time attendees):

Kalyan Ghosh, Inference Inc,
Andy Mulchinski, Symbio
Justin Gundelach, Mayo Clinic
Pauline Luong, Creative Clinical R & D
Chris Bergey, NaviDx
Brian Langin, Matrix Medical
Ravipal Luthra, University of Miami College of Medicine
Jon Matheus,  A.T. Pancrazi Real Estate Services, Inc.
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Nielson, Global Life Sciences Alliance

Screenshots of the attendees can be seen here: https://globallifesciencesalliance.com/february-networking-meeting-summary/

 

 

 

January Networking Meeting Summary

On January 19, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the first event of the new year and we had 3 first-time attendees.  

We kept everyone in one main room and went around the room having each person introduce themselves.  There was an open dialog and discussion on a variety of topics: expectations for COVID cases and treatments, the impact on travel and conventions/conferences and hopes for it to lessen and burn out and become similar to seasonal flu. The concern for another variant that could put us into strict measures is real yet the thought of having to deal with that makes us tired.

Heal Mary, (https://healmaryapp.com/) a GLSA client is an oncology patient recruitment platform founded by Cassandra Hui. Cass is from the tech industry and she started Heal Mary driven by her personal story: “My mom was told to go home and get her affairs in order, that there were no other options… I’ve made it my mission to ensure that patients know ALL of their options.” We showed a video of Cass explaining the motivation for starting Heal Mary using her tech and Artificial Intelligence skills to make sure patients know of treatment options available via clinical trials. https://www.youtube.com/channel/UCLB_CmGY3-trX3rKePF0FWw

Please join us next month on February 16.  Kalyan Ghosh of Inference, a data management  and biostatistics service provider and client of GLSA will spend 10 minutes talking about the role of data management and biostatistics in drug development.

ATTENDEES (bolded names were first time attendees):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates
Kate Findlen, Life Molecular Imaging
Kimberly Lupo, Portrett Pharmaceuticals
Mike O’Gorman, Life Science Marketplace
Andy Mulchinski, Symbio
Brian Langin, Matrix Medical
Charlie Speno, Matrix Medical
Michael W. Young, biomedwoRx: Life Sciences Consulting
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly  Cliffe, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance

Screenshots of the event follow:

Screen Shots

Virtual Networking Meeting Summary

On December 15, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was our year-end event and we didn’t have a speaker, topic or theme.

We kept everyone in one room and went around the room asking people to answer a variety of questions. We asked for each person to share what positive or memorable thing happened in 2021 and what they were looking forward to happening in 2022.

  • A representative answer was that while some had caught COVID and it was a bad illness, no one had anyone in their families get severely ill or pass away from it. The outlook for 2022 was felt to be somewhat tentative with the global rise of infections due to the Omicron variant. It was noted that the annual January JP Morgan conference will be virtual again due to the rise in cases. (Occurring today, December 22, Pfizer’s oral dose anti-viral pill to treat COVID was approved.)
  • Michael Young shared that 2021 found him becoming a grandfather with the birth of grandson Oliver Kiesing Miller (pictures below attendee listing). Michael’s hopes for 2022 include completing the first draft of a book he’s writing on “Branding”. He also echoed the feelings of many of us – having the opportunity to see clients, customers and friends in person and a return to in-person conferences. (I think this is the equivalent of a blood transfusion for extroverts).
  • Ires Alliston shared that she is hosting a Female Expert Coaches Summit May 9 – 11 in Daytona Beach, FL. More information is available here: (https://femceosummit.com/).

Movies/TV shows people are watching/recommending:

  • You
  • The Unforgiveable
  • Get Back
  • Curb Your Enthusiasm
  • Giri/Haji
  • Yellowstone

Fountain pens
It turns out that Nadia Bracken has found the hobby of collecting fountain pens. Someone else on the call mentioned a former boss who also did so.  There was a discussion about the psychological draw toward collecting such pens.  I subsequently found this discussion group (https://www.fountainpennetwork.com/forum/topic/136590-pen-personality/) .The hobby appears to be more associated with introversion based on the non-controlled survey in the discussion group. Another article on the topic is: https://www.inkedhappiness.com/fountain-pen-collecting-the-psychology-behind-my-madness/

Toward the end of the event, two things occurred after some had dropped off:

  • Dan Weddle sang and played his guitar
  • Michael Young arrived and showed pictures of his adorable 1st grandson

Please join us next month on January 19

ATTENDEES (bolded names were first time attendees):
Kevin Boos, Rho
Brian Horan, SupplyRx
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Ires Alliston, Business Coach, Consulting & Marketing
Chris Bergey, Humphries Insurance Agency
Nadia Bracken, Medidata
Dan Weddle, AltaSciences
Mike O’Gorman, Life Science Marketplace
Patrick Champoux, SkillPad
Maria Frane, Simbec-Orion
Sara Tylosky, Farmacon
Brennan Munley, Rho
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Photo Collection

Esteemed Industry Professionals
Revered Industry Professionals
Heralded clinical research industry professionals
Dan Weddle performing an original song
Denise, Zulma and Michael concluding the meeting
Oliver Kiesing Miller, grandson of Michael Young
Oliver Kiesing Miller, grandson of Michael Young